These results suggested that CCL17/CCL22-CCR4 axis was required for TAMs-CM to communicate with CRC cells by activating aggregation of ER calcium, and the ER calcium aggregation and ATF6 activation were the key upstream events of GRP78 upregulation that induced by TAMs-CM treatment. This evidence concerns the gene CCL17 and colorectal carcinoma.